Ian Henrich, PhD

Vice President, Research
and Development
Ian Henrich, PhD

Dr. Henrich is the co-inventor of USP6 mRNA technology and a co-founder of MERLIN Biotech Sciences. He completed his Ph.D. in Pharmacology from the University of Pennsylvania in 2018 under the supervision of Dr. Margaret Chou where he authored the first publications describing the unique anti-tumor properties of USP6. He continued his research as a post-doctoral researcher in Dr. Chou’s lab to parlay his thesis into cancer therapeutic and has joined MERLIN Biotech to spearhead the commercialization of USP6 and lead the discovery and development of additional oncology assets.

OTHER MANAGEMENT MEMBERS

Randall N. Hyer, MD, PhD, MPH

Chief Executive Officer

VIEW PROFILE

Nikhil A. Heble, PharmD, JD

President

VIEW PROFILE

Ju-Tao Guo, MD

Chief Scientific Officer

VIEW PROFILE

Louis P. Kassa, III, MPA

Chief Business Officer

VIEW PROFILE

Lily Paulovic

Business Development and
Operations Manager

VIEW PROFILE